Sang Joon Lee Selected Research

Macular Degeneration (Age-Related Maculopathy)

11/2021	The effect of initial intravitreal tissue plasminogen activator and gas injection on vision improvement in patients with submacular haemorrhage associated with age-related macular degeneration.
1/2020	Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.
5/2015	Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Joon Lee Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 06/2003
21	Rheumatoid Arthritis 11/2022 - 10/2013
9	Endophthalmitis (Ophthalmia) 01/2023 - 02/2013
7	Inflammation (Inflammations) 01/2024 - 09/2016
7	Breast Neoplasms (Breast Cancer) 05/2023 - 09/2008
5	Ankylosing Spondylitis 01/2021 - 10/2013
5	Stomach Neoplasms (Stomach Cancer) 12/2018 - 09/2015
5	Malaria 11/2016 - 12/2013
4	Infections 11/2021 - 08/2015
4	Macular Edema 01/2021 - 06/2011
4	Crohn Disease (Crohn's Disease) 01/2021 - 01/2015
4	Cataract (Cataracts) 11/2020 - 04/2015
4	Neoplasm Metastasis (Metastasis) 02/2017 - 09/2008
4	Carcinoma (Carcinomatosis) 09/2015 - 03/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2014 - 09/2012
3	COVID-19 08/2022 - 10/2021
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 07/2013
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 08/2017
3	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 05/2015
3	Ulcerative Colitis 01/2021 - 01/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2015
3	Hypertension (High Blood Pressure) 01/2020 - 12/2012
3	Embolism (Embolus) 09/2019 - 01/2016
3	Wounds and Injuries (Trauma) 06/2018 - 12/2013
3	Pathologic Constriction (Stenosis) 01/2017 - 04/2013
3	Neovascular Glaucoma 08/2014 - 03/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 03/2014
2	Vitreous Hemorrhage 01/2022 - 01/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2021 - 07/2009
2	Dehydration (Water Stress) 02/2020 - 12/2010
2	Hemorrhage 01/2020 - 06/2018
2	Diabetes Mellitus 01/2020 - 02/2016
2	Retinal Degeneration 12/2019 - 01/2018
2	Pain (Aches) 06/2018 - 01/2017
2	Vascular Diseases (Vascular Disease) 08/2017 - 07/2014
2	Neutropenia 08/2017 - 01/2017
2	Adenocarcinoma 07/2017 - 09/2015
2	Fibrosis (Cirrhosis) 01/2017 - 07/2016
2	Splenomegaly 11/2016 - 10/2015
2	Carcinogenesis 07/2016 - 06/2003
2	Retinal Detachment (Retinal Detachments) 10/2012 - 09/2008
2	Colonic Neoplasms (Colon Cancer) 08/2011 - 02/2011

Drug/Important Bio-Agent (IBA)

20	Biosimilar PharmaceuticalsIBA 08/2021 - 10/2013
14	CT-P13IBA 01/2021 - 10/2013
11	Infliximab (Remicade)FDA Link 01/2021 - 10/2013
10	Rituximab (Mabthera)FDA Link 01/2022 - 01/2017
10	CT-P10IBA 01/2022 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2015
5	Trastuzumab (Herceptin)FDA Link 05/2023 - 01/2017
5	Retinaldehyde (Retinal)IBA 12/2019 - 03/2009
5	FlavonoidsIBA 08/2018 - 12/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2013
4	Bevacizumab (Avastin)FDA Link 09/2015 - 06/2009
3	CT-P6IBA 05/2023 - 01/2017
3	Adalimumab (Humira)FDA Link 11/2022 - 01/2021
3	regdanvimabIBA 08/2022 - 10/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2015
3	GoldIBA 06/2015 - 01/2013
2	Epidermal Growth Factor (EGF)IBA 05/2023 - 08/2021
2	Hyaluronic Acid (Hyaluronan)IBA 01/2023 - 12/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 08/2017
2	CT-P17IBA 11/2022 - 01/2021
2	Monoclonal AntibodiesIBA 08/2022 - 10/2021
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 01/2020
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2021
2	Moxifloxacin (Avelox)FDA Link 01/2021 - 01/2019
2	Retinal Pigments (Pigments, Visual)IBA 01/2021 - 04/2016
2	afliberceptIBA 01/2020 - 03/2017
2	Vancomycin FDA LinkGeneric 06/2019 - 02/2013
2	Ceftazidime (Fortum)FDA LinkGeneric 06/2019 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2017
2	CaspasesIBA 01/2018 - 04/2017
2	Matrix Metalloproteinases (MMPs)IBA 02/2017 - 03/2014
2	GenisteinIBA 11/2016 - 10/2015
2	Glutathione (Reduced Glutathione)IBA 09/2016 - 12/2015
2	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 02/2016
2	Antimalarials (Antimalarial Agents)IBA 11/2015 - 12/2013
2	Coloring Agents (Dyes)IBA 08/2015 - 01/2015
2	CollagenIBA 03/2015 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 03/2011
2	matrigelIBA 12/2013 - 03/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 12/2012 - 09/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2012 - 03/2011
2	EnzymesIBA 03/2011 - 06/2003

Therapy/Procedure

12	Therapeutics 04/2022 - 03/2009
8	Injections 01/2022 - 05/2015
4	Neoadjuvant Therapy 05/2023 - 01/2017
4	Intravitreal Injections 11/2020 - 02/2013
4	Vitrectomy 04/2015 - 10/2012
3	Light Coagulation 01/2022 - 12/2005
3	Synchrotrons 01/2016 - 03/2013
2	Intraocular Lenses (Intraocular Lens) 01/2023 - 11/2021
2	Radiotherapy 02/2021 - 02/2012
2	Fluid Therapy (Oral Rehydration Therapy) 02/2020 - 12/2010
2	Biological Therapy 01/2019 - 08/2017
2	Drug Therapy (Chemotherapy) 01/2014 - 02/2012
2	Lasers (Laser) 04/2013 - 09/2008
2	Photochemotherapy (Photodynamic Therapy) 10/2009 - 07/2009